新型ウイルスのパンデミックに備えた次世代創薬研究基盤の構築

• Project/Area Number: 25K21782
• Research Category: Grant-in-Aid for Challenging Research (Pioneering)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 54:Internal medicine of the bio-information integration and related fields
• Research Institution: Japan Institute for Health Security
• Principal Investigator: 渡士 幸一 国立健康危機管理研究機構, 治療薬・ワクチン開発研究センター, 総括研究官 (40378948)
• Project Period (FY): 2025-06-27 – 2029-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥26,000,000 (Direct Cost: ¥20,000,000、Indirect Cost: ¥6,000,000); Fiscal Year 2028: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2027: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2026: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2025: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)